Biogen Inc. Archives - Market Exclusive

Home Tags Biogen Inc.

Biogen Inc. (NASDAQ:BIIB) Files An 8-K Submission of Matters to a...

ME Staff 8-k - June 20, 2019

Biogen Inc (NASDAQ:BIIB) price target lowered to $250.00 by BMO Capital...

ME Staff - March 22, 2019

BIOGEN INC. (NASDAQ:BIIB) Files An 8-K Results of Operations and Financial...

ME Staff 8-k - January 29, 2019

Biogen Inc (NASDAQ:BIIB) has coverage initiated with a Buy rating

ME Staff - December 26, 2018

Biogen Inc (NASDAQ:BIIB) gets downgraded to Market Perform by Sanford C....

ME Staff - October 19, 2018

Biogen Inc (NASDAQ:BIIB) price target lowered to $470.00 by Citigroup

ME Staff - October 8, 2018

Biogen Inc (NASDAQ:BIIB) has coverage initiated with a Overweight rating and...

ME Staff - October 1, 2018

Biogen Inc (NASDAQ:BIIB) price target set to $427.00 by Mizuho

ME Staff - July 31, 2018

Biogen Inc (NASDAQ:BIIB) price target raised to $483.00 by Citigroup

ME Staff - July 26, 2018

Biogen Inc (NASDAQ:BIIB) had its Buy rating reiterated by Cowen with...

ME Staff - July 24, 2018

12 3 Page 1 of 3

/* */

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 18, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 11, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

August 21, 2023

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Biogen Inc.

Biogen Inc. (NASDAQ:BIIB) Files An 8-K Submission of Matters to a...

Biogen Inc (NASDAQ:BIIB) price target lowered to $250.00 by BMO Capital...

BIOGEN INC. (NASDAQ:BIIB) Files An 8-K Results of Operations and Financial...

Biogen Inc (NASDAQ:BIIB) has coverage initiated with a Buy rating

Biogen Inc (NASDAQ:BIIB) gets downgraded to Market Perform by Sanford C....

Biogen Inc (NASDAQ:BIIB) price target lowered to $470.00 by Citigroup

Biogen Inc (NASDAQ:BIIB) has coverage initiated with a Overweight rating and...

Biogen Inc (NASDAQ:BIIB) price target set to $427.00 by Mizuho

Biogen Inc (NASDAQ:BIIB) price target raised to $483.00 by Citigroup

Biogen Inc (NASDAQ:BIIB) had its Buy rating reiterated by Cowen with...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY